Side-by-side financials for DMAC and AZN. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | DMAC | AZN |
|---|---|---|
| Market cap | - | $286.27 B |
| US-listed rank | - | #48 |
| Revenue (latest FY) | $500.00K | - |
| Net income (latest FY) | -$32.77M | - |
| Net margin | -6553.2% | - |
| SEC filings | 414 | 1,004 |
Full pages: DiaMedica Therapeutics Inc. and AstraZeneca PLC, or browse the full rankings.